Medication Adherence Interventions for Cardiovascular Disease in Low- and Middle-Income Countries: A Systematic

Oluwabunmi Ogungbe1, Samuel Byiringiro1, Adeola Adedokun-Afolayan2

  • 1Johns Hopkins University School of Nursing, Baltimore, MD, USA.

Insights

Improving medication adherence for cardiovascular diseases (CVD) in low- and middle-income countries (LMICs) requires multi-component strategies. Technology-enhanced, non-physician-led interventions show promise for better patient outcomes.

Area of Science:

  • Public Health
  • Cardiology
  • Health Services Research

Background:

  • Cardiovascular diseases (CVD) pose a significant health burden in low- and middle-income countries (LMICs).
  • Medication adherence is crucial for effective CVD management, but suboptimal adherence is a major challenge.
  • Interventions to improve medication adherence are vital for better health outcomes in these settings.

Purpose of the Study:

  • To systematically review interventions aimed at enhancing medication adherence among individuals with CVD in LMICs.
  • To critically evaluate the effectiveness of various intervention strategies.

Main Methods:

  • A systematic review of studies published between 2010 and 2020 was conducted.
  • Searches were performed in PubMed, Embase, and CINAHL for relevant medication adherence interventions in LMICs.
  • Studies reporting adherence as an outcome and detailing adherence measurement tools were included.

Main Results:

  • Forty-five articles were included, with most interventions involving counseling and education delivered by nurses, pharmacists, or community health workers.
  • Technology-based reminders (e.g., SMS, phone calls) and multi-component interventions were more effective than single-strategy approaches.
  • Combined patient- and provider-level interventions demonstrated a larger impact on medication adherence.

Conclusions:

  • Combined interventions, including patient education, reminders, fixed-dose combinations, and team-based care, are more effective for CVD medication adherence in LMICs.
  • Interventions were found to be moderately effective overall.
  • Future research should focus on non-physician-led and locally adapted interventions.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
99
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
441
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
93
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
218
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
83